Abstract
The 90-kDa nucleolus organizer region autoantigen (NOR-90) was previously shown to be identical to the human upstream binding factor (hUBF) and composed of twoMr forms. In this study, thirteen human anti-NOR-90/hUBF autoimmune sera were used to further characterize NOR-90/hUBF and its associated autoantigens. Nucleolar and nucleoplasmic staining of interphase cells and NOR staining in mitosis were observed with all sera by immunofluorescence. All sera showed equal reactivity with both high and lowMr forms in Western blotting and immunoprecipitation, suggesting that the cellular content and distribution for bothMr forms were approximately equal. Using extracts of [35S]methionine- and [32P]orthophosphate-labeled cells, phosphorylated and nonphosphorylated NOR-90/hUBF were identified for bothMr forms and these two populations were recognized by human autoantibodies. In immunoprecipitation analyses, the nonphosphorylated population was readily extracted while the phosphorylated population was tightly bound. Clinical data were available for 8 patients in whom anti-NOR-90/hUBF autoantibodies were present. They had diverse diagnoses including SLE, rheumatoid arthritis and malignancies. Although only one patient was diagnosed as scleroderma, Raynaud's phenomenon was observed in 4 of the 8 patients. Interestingly, one NOR-90/hUBF serum was shown to contain additional antibodies to RNA polymerases I and II.Abbreviations: ANA=Antinuclear antibody; HCC=hepatocellular carcinoma; hUBF=human upstream binding factor; NOR=nucleolus organizer region; RNA pol I=RNA polymerase I; RNA pol II=RNA polymerase II; rRNA=ribosomal RNA; SLE=systemic lupus erythematosus.
Similar content being viewed by others
References
Tan EM (1989) Adv. Immunol. 44: 93–151
Guldner HH, Szostecki C, Vosberg HP, Lakomek HJ, Penner E & Bautz FA (1986) Chromosoma 94: 132–138
Jimenez-Garcia LF, Rothblum LI, Busch H & Ochs RL (1989) Biol. Cell 65: 239–246
Matsui S & Sandberg AA (1985) Chromosoma 92: 1–6
Reimer G, Rose KM, Scheer U & Tan EM (1987) J. Clin. Invest. 79: 65–72
Rodriguez-Sanchez JL, Gelpi C, Juarez C & Hardin JA (1987) J. Immunol. 139: 2579–2584
Goessens G (1984) Int. Rev. Cytol. 87: 107–158
Ochs RL & Press RI (1992) Exp. Cell Res. 200: 339–350
Kipnis RJ, Craft J, & Hardin JA (1990) Arthritis Rheum. 33: 1431–1437
Chan EKL, Imai H, Hamel JC & Tan EM (1991) J. Exp. Med. 174: 1239–1244
Jantzen HM, Admon A, Bell SP & Tjian R (1990) Nature 344: 830–836
Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM & Tan EM (1992) Am. J. Pathol. 140: 859–870
Tan EM, Feltkamp TEW, Alarcon-Segovia D, Dawkins RL, Homma M, Kalden JR, Lambert PH, Lange A, Maini RN, McDuffie FC, McDougal JS, Norberg R & Wilson M (1988) Arthritis Rheum. 31: 1331
Thompson NE, Aronson DB & Burgess RR (1990) J. Biol. Chem. 265: 7069–7077
Chan EKL & Pollard KM (1992) In: Rose NR, Conway de Macario E, Fahey JL, Friedman H & Penn GM (Eds) Manual of Clinical Laboratory Immunology (pp 755–761) American Society for Microbiology, Washington, D. C.
Chan EKL & Tan EM (1987) J. Exp. Med. 166: 1627–1640
Terasima T & Tolmach LJ (1963) Exp. Cell Res. 30:344–362
Howell WM (1982) In: Busch H & Rothblum LI (Eds) The Cell Nucleus, vol. 11, (pp89–142) Academic Press, New York
Sentenac A (1985) CRC Crit. Rev. Biochem. 18: 31–90
Woychik NA, Liao S-M, Kolodziej PA & Young RA (1990) Genes Dev. 4: 313–323
Allison LA, Moyle M, Shales M & Ingles CJ (1985) Cell 42: 599–610
Mémet S, Gouy M, Marck C, Sentenac A & Buhler J-M (1988) J. Biol. Chem. 263: 2830–2839
Mémet S, Saurin W & Sentenac A (1988) J. Biol. Chem. 263: 10048–10051
O'Mahony DJ, Xie W-Q, Smith SD, Singer HA & Rothblum LI (1992) J. Biol. Chem. 267: 35–38
Voit R, Schnapp A, Kuhn A, Rosenbauer H, Hirschmann P, Stunnenberg HG & Grummt I (1992) EMBO J. 11: 2211–2218
Maeda Y, Hisatake K, Kondo T, Hanada K-i, Song C-Z, Nishimura T & Muramatsu M (1992) EMBO J. 11: 3695–3704
Chambon P (1975) Annu. Rev. Biochem. 44: 613–638
Kuwana M, Kaburaki J, Mimori T, Tojo T & Homma M (1993) J. Clin. Invest. 91: 1399–1404
Hirakata M, Okano Y, Pati U, Suwa A, Medsger Jr. TA, Hardin JA & Craft J (1993) J. Clin. Invest. 91: 2665–2672
Bell SP, Jantzen HM & Tjian R (1990) Genes Dev. 4: 943–954
Comai L, Tanese N & Tjian R (1992) Cell 68: 965–976
Belch JJ (1991) Ann. Rheum. Dis. 50: 839–845
Roumm AD & Medsger Jr. TA (1985) Arthritis Rheum. 28: 1336–1340
Abu-Shakra M, Guillemin F & Lee P (1993) Arthritis Rheum. 36: 460–464
Thomas PJ, Kaur JS, Aitcheson CT, Robinson WA & Tan EM (1983) Cancer Res. 43: 1372–1380
Bonfa E, Bystryn JC & Elkon KB (1988) J. Invest. Dermatol. 90: 207–212
Treré D, Farabegoli F, Cancellieri A, Ceccarelli C, Eusebi V & Derenzini M (1991) J. Pathol. 165: 53–59
Mamaev NN & Mamaeva SE (1990) Int. Rev. Cytol. 121: 233–266
Author information
Authors and Affiliations
Additional information
Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto-Shi 390, Japan
Rights and permissions
About this article
Cite this article
Imai, H., Fritzler, M.J., Neri, R. et al. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Mol Biol Rep 19, 115–124 (1994). https://doi.org/10.1007/BF00997157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00997157